Hemangioma clinical trials

The registry lists 68 studies for Hemangioma across more than 10 countries. 11 are recruiting or about to start. 47 of them are mainly about Hemangioma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 2 narrower conditions too, such as Hemangioma, Capillary: 95 studies, 17 open.

Get an email when these change. Save the Hemangioma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 34
Terminated: 10
Status unknown: 9
Recruiting: 6
Not yet recruiting: 5
Withdrawn: 2

Phase

Phase 2: 13
Phase 3: 7
Phase 4: 3
Early Phase 1: 3
Phase 1: 3

Where

United States: 28
China: 8
Canada: 4
France: 4
Egypt: 2
Spain: 2

Who runs them

Medical College of Wisconsin (6) · Assiut University (3) · University of California, Irvine (2) · Rady Children's Hospital, San Diego (2) · Southwest Hospital, China (2) · Zhujiang Hospital (2) · University of Arkansas (2) · Yonsei University (2)

What is being tested here

Drugs under test in Hemangioma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Timolol	1	0	4
Everolimus	1	0	1
Propranolol	0	3	8
Bleomycin	0	0	1
Sirolimus	0	0	1
Atenolol	0	1	1
Nadolol	0	1	1
Prednisone	0	0	1
Imiquimod	0	0	1
Acebutolol	0	1	1

Drug classes tested here Beta blockers 1 open

Coming up

1phase 3 study under way

3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Dec 2026A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures · Boston Children's Hospital
Dec 2026Fluctuational Imaging for the Diagnosis of Hepatic Hemangioma: A Multicenter, Prospective Study · Yonsei University
Jan 2027Radiological Diagnosis of Pediatric Neck Swellings · Sohag University

Who these studies take

Of the 6 Hemangioma studies recruiting now, 2 (33%) set no upper age limit and 3 (50%) stop at 75 or younger. 3 (50%) take children under 18. 1 (17%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	1 (17%)	1 (17%)
18	3 (50%)	2 (33%)
30	4 (67%)	3 (50%)
40	4 (67%)	3 (50%)
50	3 (50%)	3 (50%)
65	3 (50%)	3 (50%)
75	3 (50%)	3 (50%)
85	3 (50%)	3 (50%)

Across all 68 studies, recruiting or not: 66% stop at 75 or younger and 60% at 65; 75% take children; 3% are for women only and 1% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Using an Artificial Intelligence (AI) Tool for Melanoma DiagnosisOct 22, 2026NCT07890415

Studies

Recruiting first, then most recently updated. Showing 50 of 68. Browse all 68 → or search them.